Skip Nav Destination
EVIDENCE-BASED MINIREVIEW|
December 8, 2023
Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?
Evidence-Based Minireview
Erin E. Doherty,
Baylor College of Medicine, Cell and Gene Therapy Department, Texas Children's Hospital, Houston, TX
Correspondence Erin E. Doherty, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030; e-mail: eedohert@texaschildrens.org.
Search for other works by this author on:
Robert A. Krance
Robert A. Krance
Baylor College of Medicine, Cell and Gene Therapy Department, Texas Children's Hospital, Houston, TX
Search for other works by this author on:
Hematology Am Soc Hematol Educ Program (2023) 2023 (1): 171–174.
Citation
Erin E. Doherty, Robert A. Krance; Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?. Hematology Am Soc Hematol Educ Program 2023; 2023 (1): 171–174. doi: https://doi.org/10.1182/hematology.2023000522
Download citation file:
My Account
Sign In
December 8 2023